ReviewTranslational breast cancer research : a journal focusing on translational research in breast cancer2026
Clinical practice guidelines for prognosis and follow-up of early-stage breast cancer patients: Chinese Society of Breast Surgery (CSBrS) practice guidelines (2026 edition) Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association.
Review in Translational breast cancer research : a journal focusing on translational research in breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Long-term survival in early-stage breast cancer patients has markedly improved, making follow-up an increasingly prolonged phase of care. Accurate prognosis assessment and a scientifically grounded follow-up plan are essential for achieving effective and individualized chronic disease management. This guideline aims to standardize these practices in China. Methods: The Chinese Society of Breast Surgery (CSBrS) convened a panel of experts. Clinical evidence was assessed according to a modified GRADE system. Recommendations were developed by integrating evidence quality with practical feasibility in the Chinese healthcare setting. A consensus voting committee of 33 breast surgeons graded the recommendation strength (Level A: ≥90% agreement; Level B: 80-89% agreement). Results: This guideline centers on two core components: prognosis and follow-up. A comprehensive prognosis integrates four domains: patients' general health, including age, genetic risk, reproductive history, and past medical history; tumor staging and histopathological characteristics; molecular features like subtype, Ki-67, Conclusions: This guideline provides evidence-based, consensus-driven recommendations for the prognostic evaluation and follow-up of early-stage breast cancer patients in China. Adopting this guideline within a multidisciplinary, patient-centered framework is vital for enhancing long-term survival and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.